Manuela Mancini

1.8k total citations
60 papers, 1.1k citations indexed

About

Manuela Mancini is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Manuela Mancini has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 26 papers in Genetics and 24 papers in Molecular Biology. Recurrent topics in Manuela Mancini's work include Chronic Myeloid Leukemia Treatments (40 papers), Chronic Lymphocytic Leukemia Research (26 papers) and Eosinophilic Disorders and Syndromes (12 papers). Manuela Mancini is often cited by papers focused on Chronic Myeloid Leukemia Treatments (40 papers), Chronic Lymphocytic Leukemia Research (26 papers) and Eosinophilic Disorders and Syndromes (12 papers). Manuela Mancini collaborates with scholars based in Italy, United States and Czechia. Manuela Mancini's co-authors include Giovanni Martinelli, Simona Soverini, Maria Alessandra Santucci, Michèle Cavo, Valentina Corradi, Luana Bavaro, Elena Barbieri, Caterina De Benedittis, Maurizio Botta and Fabrizio Manetti and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Manuela Mancini

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuela Mancini Italy 21 500 483 325 180 143 60 1.1k
Maria Alessandra Santucci Italy 17 296 0.6× 432 0.9× 112 0.3× 136 0.8× 63 0.4× 49 740
Kathy Rocha United States 7 368 0.7× 1.1k 2.3× 169 0.5× 261 1.4× 49 0.3× 13 1.3k
Boris Kovačic Austria 17 461 0.9× 463 1.0× 354 1.1× 692 3.8× 117 0.8× 25 1.4k
Veronica Novotny‐Diermayr Singapore 14 225 0.5× 596 1.2× 224 0.7× 380 2.1× 38 0.3× 19 986
Heriberto Bruzzoni‐Giovanelli France 15 179 0.4× 570 1.2× 120 0.4× 281 1.6× 89 0.6× 23 932
Janet L. Anderl United States 16 366 0.7× 774 1.6× 63 0.2× 378 2.1× 47 0.3× 28 1.0k
Roland Grenningloh United States 22 164 0.3× 414 0.9× 332 1.0× 259 1.4× 123 0.9× 39 1.4k
Magali Herrant France 10 180 0.4× 637 1.3× 106 0.3× 200 1.1× 31 0.2× 11 883
Sarah J. Neering United States 7 928 1.9× 1.3k 2.7× 191 0.6× 414 2.3× 32 0.2× 12 1.9k
Anuhar Chaturvedi Germany 18 614 1.2× 665 1.4× 251 0.8× 127 0.7× 25 0.2× 33 1.1k

Countries citing papers authored by Manuela Mancini

Since Specialization
Citations

This map shows the geographic impact of Manuela Mancini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Mancini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Mancini more than expected).

Fields of papers citing papers by Manuela Mancini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Mancini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Mancini. The network helps show where Manuela Mancini may publish in the future.

Co-authorship network of co-authors of Manuela Mancini

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Mancini. A scholar is included among the top collaborators of Manuela Mancini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Mancini. Manuela Mancini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mancini, Manuela, Cristina Papayannidis, Michela Rondoni, et al.. (2023). SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted. Biomarker Research. 11(1). 29–29. 4 indexed citations
2.
Mancini, Manuela & Åsmund Rinnan. (2023). Classification of waste wood categories according to the best reuse using FT-NIR spectroscopy and chemometrics. Analytica Chimica Acta. 1275. 341564–341564. 8 indexed citations
3.
Soverini, Simona, Maurizio Martelli, Fausto Castagnetti, et al.. (2022). Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia. Leukemia. 36(9). 2250–2260. 14 indexed citations
4.
Mancini, Manuela, et al.. (2022). Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 12 indexed citations
5.
Gagliardi, Monica, Grazia Annesi, Maurizio Morelli, et al.. (2018). DNAJC13 mutation screening in patients with Parkinson's disease from South Italy. Parkinsonism & Related Disorders. 55. 134–137. 13 indexed citations
6.
Mancini, Manuela, Cristina Papayannidis, Michela Rondoni, et al.. (2017). Polo-like Kinase-1 and Aurora Kinase A As Novel Therapeutic Targets in Neoplastic Mast Cells. Blood. 130. 5290–5290. 1 indexed citations
7.
Mancini, Manuela, Ken‐Ichi Takemaru, Fausto Castagnetti, et al.. (2015). 14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia. PLoS ONE. 10(7). e0131074–e0131074. 14 indexed citations
8.
Soverini, Simona, Caterina De Benedittis, Manuela Mancini, & Giovanni Martinelli. (2015). Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 15. S120–S128. 49 indexed citations
9.
Mancini, Manuela, Ken‐Ichi Takemaru, Enrica Borsi, et al.. (2013). Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells. Cellular Signalling. 25(9). 1820–1827. 16 indexed citations
10.
Mancini, Manuela, Nevena Veljković, Michela Aluigi, et al.. (2012). Cytoplasmatic compartmentalization by Bcr‐Abl promotes TET2 loss‐of‐function in chronic myeloid leukemia. Journal of Cellular Biochemistry. 113(8). 2765–2774. 14 indexed citations
11.
Corradi, Valentina, Manuela Mancini, Maria Alessandra Santucci, et al.. (2011). Computational techniques are valuable tools for the discovery of protein–protein interaction inhibitors: The 14-3-3σ case. Bioorganic & Medicinal Chemistry Letters. 21(22). 6867–6871. 30 indexed citations
12.
Mancini, Manuela, et al.. (2010). Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. Cellular Signalling. 22(8). 1247–1253. 32 indexed citations
13.
Mancini, Manuela, Valentina Corradi, Elena Barbieri, et al.. (2010). A New Nonpeptidic Inhibitor of 14-3-3 Induces Apoptotic Cell Death in Chronic Myeloid Leukemia Sensitive or Resistant to Imatinib. Journal of Pharmacology and Experimental Therapeutics. 336(3). 596–604. 50 indexed citations
14.
Agostinelli, Claudio, Elena Sabattini, Simona Righi, et al.. (2010). Characterization of a New Monoclonal Antibody Against PAX5/BASP in 1525 Paraffin-embedded Human and Animal Tissue Samples. Applied immunohistochemistry & molecular morphology. 18(6). 561–572. 20 indexed citations
15.
Mancini, Manuela, et al.. (2009). RAD 001 (everolimus) prevents mTOR and Akt late re‐activation in response to imatinib in chronic myeloid leukemia. Journal of Cellular Biochemistry. 109(2). 320–328. 24 indexed citations
16.
Zuffa, Elisa, Manuela Mancini, Eleonora Pagnotta, et al.. (2008). P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2. International Journal of Radiation Biology. 84(7). 591–601. 6 indexed citations
17.
Radi, Marco, Emmanuele Crespan, Giorgia Botta, et al.. (2007). Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. Bioorganic & Medicinal Chemistry Letters. 18(3). 1207–1211. 50 indexed citations
18.
Mancini, Manuela, Elisa Zuffa, Giovanni Martinelli, et al.. (2006). Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606. Leukemia Research. 31(7). 979–987. 22 indexed citations
19.
Mazzacurati, Lucia, Laura Pattacini, Manuela Mancini, et al.. (2004). Chk2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571. The Hematology Journal. 5(2). 168–177. 12 indexed citations
20.
Pattacini, Laura, Manuela Mancini, Lucia Mazzacurati, et al.. (2003). Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr–abl tyrosine kinase. Leukemia Research. 28(2). 191–202. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Alessandra Santucci Breakdown of academic impact, for papers by Kathy Rocha Breakdown of academic impact, for papers by Boris Kovačic Breakdown of academic impact, for papers by Veronica Novotny‐Diermayr Breakdown of academic impact, for papers by Heriberto Bruzzoni‐Giovanelli Breakdown of academic impact, for papers by Janet L. Anderl Breakdown of academic impact, for papers by Roland Grenningloh Breakdown of academic impact, for papers by Magali Herrant Breakdown of academic impact, for papers by Sarah J. Neering Breakdown of academic impact, for papers by Anuhar Chaturvedi
Rankless by CCL
2026